Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction
Results of long-term follow-up
J.ürg Schläpfer, MD*,*,
Fabrice Rapp, MD*,
Lukas Kappenberger, MD, FACC* and
Martin Fromer, MD*
* Division of Cardiology, University Hospital (CHUV), Lausanne, Switzerland
View larger version (11K):
[in a new window]
|
Figure 1 Global survival was significantly better among patients treated with the implantable cardioverter-defibrillator (ICD), compared with amiodarone.
|
|
View larger version (11K):
[in a new window]
|
Figure 2 Freedom from sudden cardiac death. The sudden cardiac death rate was significantly lower in patients treated with the implantable cardioverter-defibrillator (ICD), compared with amiodarone.
|
|
|
